Christine S

Kaiser California Pathologist. Tweets are me. Cheers.

[Dr Kamlesh Darji @DrKamleshDarji1]

Liver biopsy - Identify the structures (A,B and C) #INICET

[Janira Navarro @Janiranavarro]

Skin: Problematic Cases - Squamous Proliferations

Looks like actinic keratosis or verrucous keratosis but is broadly transected
How to sign it out?

Dr. Kang #JobPrepBootcamp #NIPCAP #pathology #PathX #PathTwitter

[Aasma Shaukat MD MPH @AasmaShaukatMD]

One of my former research assistants was killed by ICE in Minneapolis today😢

Alex was the kindest, sweetest human and a ICU nurse with a bright future ahead of him
May his soul rest in peace and this senseless carnage stop💔

[The British Assoc of Gynaecological Pathology @BAGPGynPath]

Calling all #GynaePath trainees 📣
Join our FREE Gynaecological Pathology Trainee Meeting
🔬 23 Feb: Practical Grossing
🔬 16 Nov: Practical Morphology
✨ Register once (23 Feb) = access to BOTH meetings
🔗 https://t.co/sbiAfW3Rn4
#PathTwitter #Gynaepath #Gynpath

[Kurt Schaberg @KurtSchaberg]

I just finished my notes on Tumors of the Endometrium and posted them to my teaching website, Kurt's Notes: https://t.co/OKmaPvoHbB

Tumors of the Endometrium: https://t.co/Gs4dvFiTRF

@NatalieBanet @shyamraghavan @SteveLongMD

[lucia ribero @luribero26]

💎- Is PORTEC-4a the tipping point in endometrial cancer management? - The Lancet Oncology https://t.co/3MrOo0qJBB

[soria @jsoriamd]

🧬 MSI-H = hallmark of mismatch repair (MMR) deficiency.
🧵 Prevalence: ~30% endometrial, ~10% CRC, ~8% gastric.
But not all MSI-H/dMMR tumors are alike:
1️⃣ MSH2/MSH6 loss → ↑ TMB, better ICI response
2️⃣ PTEN/AKT1 mutations → ICI resistance
Checkpoint blockade is now 1L in CRC & endometrial.
#MSI #Immunotherapy #Biomarkers
🔗 https://t.co/E7eGcMtJUy

[International Society of Gynecologic Pathologists @ISGynP]

Announcing a free @ISGynP sponsored live virtual webinar on 04/03 by Dr. Hoang "A Panorama of Vulvar Cancer". Register now at https://t.co/uIM5YcRQ6l #gynpath #pathtwitter #pathology

[Charlie Herndon @DrCycloPath]

70yo ♀ vulva, diagnosis?
A) adenoid basal carcinoma
B) adenoid cystic carcinoma
C) mesonephric hyperplasia
D) mesonephric carcinoma
🔬https://t.co/bckSaAZvT7
#GYNPath #PathTwitter #Pathology

[Ankur Sangoi @slusagar]

#GUpath TURBT:

yes, typical tubular/cystic elements of nephrogenic adenoma (🥱)
but also...flat pattern NA😲

[Gerônimo Jr. @GeronimoJrLapac]

#gipath #pathology

[Ankur Sangoi @slusagar]

#GUpath bladder bx:

diagnostic approach?🤨next steps?

see more 🔬cases like this at our upcoming @TheUSCAP #InteractiveMicroscopy course in🌴😎 Palm Springs next month!

reserve your spot now!
👉🏽https://t.co/UQiV5eygUH👈🏽

[Bin Xu @BinXu16]

Sinonasal papilloma side-by-side comparison with a bonus summary table. #ENTpath #pathobard #pathology101

@TheKarenPinto @kriyer68 @DrAhmedKalebi @kabeerkshah @aakasharmand @smlungpathguy @sam_albadri @Sara_Jiang @bansar_bansaria @ycharzy @DrAldehyde @luishcruzc @DrGeeONE

[Charlie Herndon @DrCycloPath]

Fibroblastic focus: reserved for UIP (honeycomb + foci + heterogeneous)
🔬https://t.co/UudJjxIVWr
🎥https://t.co/KpQg84K7te
Fibroblastic plug: fibroblasts plugging up airspaces (eg OP)
🔬https://t.co/Yqfo2m3CZz
🎥https://t.co/QljvPnJb02
🎥🙏@Path_Matt
✅Focus (case of UIP)

[Scott Kilpatrick, MD @ScottBikeethan]

Non-uniform cellularity, particularly if it is more prominent peripherally, coupled with significant atypia strongly favors chondroblastic osteosarcoma, even in the absence of definite osteoid/bone production on biopsy. Of course, on resection you'll find it at least focally.

[Christine S @cjsalibay]

@BAGPGynPath Any means to access this particular lecture ? Thank you.

[Natasha Rekhtman MD PhD @natasharekhtman]

Great example of a benign entity that can mimic mucinous lung adenocarcinomas. Thanks so much for the shout-out @feidng @lmsholl @BWHPath! Here is another example ... from one of my first #PulmPath posts. https://t.co/MSjq9qxs19

[Brigham and Women's Pathology @BWHPath]

Frozen section for a 6 mm lung nodule. What is the diagnosis?

#BWHPathCOTW #Pulmpath

1/4

[International Society of Gynecologic Pathologists @ISGynP]

Join the virtual 3rd ISGyP Annual Meeting "Making diagnoses in gynaecological pathology 2023 FIGO staging of endometrial carcinomas", Oct 21, for free! Expert lectures in #gynpath Open to all pathologists &
trainees. Register free at https://t.co/uIM5YcRQ6l
#pathology

[Christine S @cjsalibay]

@olsonplanner Should start a group - how much did I lose out on when I refinanced and found out Kaiser randomly qualifies for PSLF